摘要:
A method for the preparation of Mycobacteria from any liquid, semisolid or exotic source is described. The extracted Mycobacterial sample is suitable for detection by culture and amplification.
摘要:
The present invention relates to a method for enhancing the time of response of an assay for a first bacterium, characterised in that: a) the said first bacterium is exposed to infection by phage particles to which the said first bacterium is permissive; b) the infected bacterium is treated to in-activate exogenous phage particles; c) the treated bacterium is cultivated in the presence of a second bacterium which is permissive to said phage or its replicand and which has a doubling rate greater than the effective doubling rate of the first bacterium; and d) assessing the extent of plaque formation and/or of second bacterium growth in the cultivated second bacterium cells. The method of the invention can be used to assess the presence of first bacterium in a sample, notably where the first bacterium is a slow growing bacterium, especially Mycobacterium tuberculosis, where the method of the invention enables an operator to detect the presence of low amounts of the bacterium in a sample within days instead of the weeks required with conventional bacterial cultivation techniques. The invention can also be used to assess the effect of a drug or other treatment on a bacterium or of a virus. The invention also provides a diagnostic kit for use in the method of the invention.
摘要:
The invention relates to the nucleic acid sequence and amino acid sequence of dihydrofolate reductase (DHFR) from mycobacteria and to expression of recombinant DHFR protein. Utilizing the recombinant protein, novel therapies and diagnostic strategies can be developed and selective antimycobacterial compositions can be designed and utilized to treat mycobacterial infections in patients. This invention includes all or portions of novel recombinant nucleic acids encoding DHFR for mycobacteria such as M. avium, to novel recombinant DHFR peptides produced by such sequences, and to vaccines, diagnostic kits, cells and therapies utilizing these peptides and nucleic acid sequences. The present invention relates to methods for using the sequences of the present invention to develop drugs specific to M. avium and other mycobacteria, to identify and sequence corresponding sequences in species other than M. avium, as well as diagnostic and treatment methods incorporating the disclosed sequences and peptides.
摘要:
L'invention concerne un procédé d'isolement de l'antigène A 60, un procédé de production de fragments immunologiquement actifs à partir de celui-ci; leur utilisation pour détecter dans un sérum d'un mammifère la présence d'anticorps contre l'antigène A 60 ainsi qu'un procédé de détection de tels anticorps. Le procédé d'isolement est caractérisé en ce qu'il comprend une étape de destruction des parois cellulaires de la mycobactérie: on sépare les débris cellulaires, notamment par centrifugation, on récolte le surnageant contenant le cytoplasme; on réalise une chromatographie d'exclusion en faisant passer le surnageant contenant le cytoplasme sur une colonne de gel d'exclusion et on récolte le pic d'exclusion contenant l'antigène A 60 substantiellement pur. A partir de l'antigène A 60 ainsi isolé, on peut produire des fragments immunologiquement actifs; utiliser cet antigène et/ou ses fragments immunologiquement actifs à la détection d'anticorps et réaliser ainsi un procédé de détection desdits anticorps.
摘要:
Exochelins can be used to prevent damage to living tissue from the formation or presence of the (.OH) radical. In particular, the invention is directed to the administration of exochelins to infarcted myocardium prior to or coincidental with reperfusion to prevent damage to myocardium from iron mediated free radical formation. Also presented is the chemical structure of exochelins and modified exochelins as well as other applications of these materials in the treatment and diagnosis of disease in mammals.
摘要:
The present invention relates to genetically recombinant (genetically engineered) mycobacteria which express DNA of interest which has been incorporated into the mycobacteria and is expressed extrachromosomally (episomally or autonomously) in the recombinant mycobacteria under the control of a promoter. It particularly relates to recombinant M. bovis-BCG in which DNA of interest is expressed extrachromosomally under the control of a mycobacterial hsp promoter, such as hsp70 and hsp60. DNA of interest is defined herein as heterologous DNA (i.e., DNA from a source other than the mycobacterium into which it is introduced) and is all or a portion of a gene or genes encoding enzymes, cytokines, lymphokines and immunopotentiators.
摘要:
This invention provides for novel attenuated strains of Mycobacterium tuberculosis and M. bovis. Attenuation is achieved by eliminating or by downregulating the expression of the α-crystallin heat shock protein gene ('acr gene'). The invention provides for vaccines and methods of vaccinating mammals for protection against Mycobacterium sp. that cause tuberculosis.
摘要:
A method of speciating and identifying MAI in a specimen comprises placing a paraffin coated slide in a receptacle containing a sterile aqueous solution inoculated with the specimen, analyzing the slide after exposure to the specimen to determine the presence or absence of atypical Mycobacteria, and after the analysis step, if atypical Mycobacteria are determined to be present, performing at least one speciation assay to ascertain if the atypical Mycobacteria are MAI. A related apparatus is also disclosed for speciating and identifying MAI in a specimen comprising a paraffin-wax coated slide, a tube having a sterile aqueous solution contained therein, the tube adapted to hold the slide, and at least one speciation assay means for performing an assay to determine the presence or absence of MAI in the speciment after the speciment is introduced into the tube holding the solution and the slide. An apparatus and method for determining the sensitivity of MAI to different antibiotics and dosages thereof is also provided.